Skip to content

Research and Development of Key Technologies for Intelligent Minimally invasive and Precise Treatment of Fractures (Project 2: Randomized Controlled Study on Robot-Assisted Closed Reduction and Internal Fixation of Femoral Shaft Fractures)

Research and Development of Key Technologies for Intelligent Minimally invasive and Precise Treatment of Fractures (Project 2: Randomized Controlled Study on Robot-Assisted Closed Reduction and Internal Fixation of Femoral Shaft Fractures)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600124701
Enrollment
Unknown
Registered
2026-05-15
Start date
2026-05-15
Completion date
Unknown
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

femoral shaft fracture

Interventions

Sponsors

Beijing Jishuitan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age: 18 to 80 years old, gender not limited; 2. Diagnosed as unilateral, acute, closed femoral shaft fracture (AO/OTA 32-A/B/C); 3. No more than 21 days from injury to surgery; 4. Before the injury, the individual could walk independently (assistive devices are allowed).

Exclusion criteria

Exclusion criteria: 1. Open fractures or multiple severe traumas that require priority treatment; 2. Asymmetry of both lower extremities or previous malunion of the ipsilateral femoral shaft or previous malformations that significantly affect rotation/length assessment; 3. Fractures in other parts on the same side; 4. Pathological fractures (tumors or metabolic bone diseases); 5. Previous complex implants on the same side or previous surgeries have a significant impact on the assessment; 6. Active infections or severe internal diseases that make surgery intolerable; 7. Cognitive impairment, poor compliance, pregnancy or lactation; 8. Those who the researcher deems unsuitable for inclusion in the group (such as those who cannot complete the follow-up); 9. Refuse randomization or refuse to participate in the researcher.

Design outcomes

Primary

MeasureTime frame
The excellent and good rate of closed reduction;

Secondary

MeasureTime frame
Time of operation;Number of X-ray exposures;Peroperative bleeding;Detention time;Fracture healing rate;EuroQol 5-Dimension 5-Level Score;Harris Hip Score ;

Countries

China

Contacts

Public ContactZhao Chunpeng

Beijing Jishuitan Hospital, Capital Medical University

Zcpllza2008@163.com+86 186 1001 2704

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 22, 2026